Shares of Cardinal Health, Inc. (NYSE:CAH - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the fourteen ratings firms that are currently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $158.07.
CAH has been the subject of a number of research reports. Citigroup reaffirmed a "neutral" rating and issued a $170.00 price objective (up from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Evercore ISI reaffirmed an "outperform" rating and issued a $180.00 price objective (up from $175.00) on shares of Cardinal Health in a research note on Thursday, June 12th. Bank of America lifted their price objective on Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research note on Tuesday, June 10th. Morgan Stanley boosted their target price on Cardinal Health from $181.00 to $190.00 and gave the stock an "overweight" rating in a research note on Wednesday. Finally, Wells Fargo & Company raised Cardinal Health from an "equal weight" rating to an "overweight" rating and upped their price objective for the stock from $136.00 to $179.00 in a research report on Tuesday, June 3rd.
Check Out Our Latest Stock Report on CAH
Cardinal Health Stock Down 0.0%
NYSE:CAH traded down $0.01 on Wednesday, reaching $159.45. The company's stock had a trading volume of 2,035,339 shares, compared to its average volume of 2,236,166. Cardinal Health has a 12-month low of $94.29 and a 12-month high of $168.44. The firm has a market cap of $38.06 billion, a price-to-earnings ratio of 24.88, a price-to-earnings-growth ratio of 1.58 and a beta of 0.68. The stock has a 50 day moving average price of $158.68 and a 200 day moving average price of $140.19.
Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. The company had revenue of $54.88 billion for the quarter, compared to the consensus estimate of $55.33 billion. During the same quarter in the previous year, the business earned $2.08 earnings per share. The company's revenue for the quarter was up .0% on a year-over-year basis. Equities research analysts expect that Cardinal Health will post 7.95 EPS for the current fiscal year.
Cardinal Health Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st were issued a dividend of $0.5107 per share. The ex-dividend date was Tuesday, July 1st. This is a positive change from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.04 annualized dividend and a dividend yield of 1.28%. Cardinal Health's dividend payout ratio is 31.83%.
Institutional Investors Weigh In On Cardinal Health
Institutional investors have recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB increased its stake in shares of Cardinal Health by 3.6% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company's stock worth $297,000 after acquiring an additional 62 shares during the last quarter. Perigon Wealth Management LLC grew its position in shares of Cardinal Health by 3.2% in the second quarter. Perigon Wealth Management LLC now owns 2,314 shares of the company's stock valued at $389,000 after purchasing an additional 72 shares during the last quarter. Community Bank & Trust Waco Texas grew its position in shares of Cardinal Health by 1.3% in the second quarter. Community Bank & Trust Waco Texas now owns 5,598 shares of the company's stock valued at $940,000 after purchasing an additional 74 shares during the last quarter. Pinnacle Bancorp Inc. lifted its stake in shares of Cardinal Health by 11.2% in the first quarter. Pinnacle Bancorp Inc. now owns 767 shares of the company's stock valued at $106,000 after buying an additional 77 shares during the period. Finally, G&S Capital LLC lifted its stake in shares of Cardinal Health by 0.8% in the second quarter. G&S Capital LLC now owns 9,476 shares of the company's stock valued at $1,592,000 after buying an additional 78 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.
About Cardinal Health
(
Get Free ReportCardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.